How should furosemide (Lasix) 3 mg be prepared and administered intravenously to a neonate in the NICU?

NICU Furosemide (Lasix) 3 mg IV: Preparation and Administration

For a 3 mg dose of furosemide in a neonate, draw up 0.3 mL from a 10 mg/mL vial (standard concentration), dilute if needed for accuracy, and administer as a slow IV push over 1-2 minutes, or consider continuous infusion at 0.1 mg/kg/hour for more stable diuresis with less hemodynamic fluctuation.

Preparation

Standard Concentration and Dosing

• Furosemide injection comes as 10 mg/mL in vials 1
• For a 3 mg dose: Draw up 0.3 mL from the vial
• The FDA-approved neonatal dose is 1 mg/kg IV given slowly, with maximum increases to 2 mg/kg every 24 hours in premature infants 1
• For premature infants, the maximum dose should not exceed 1 mg/kg/day according to literature recommendations 1

Dilution Considerations

• Furosemide injection has a pH of approximately 9 (buffered alkaline solution) 1
• Must not be mixed with acidic solutions (pH <7) as precipitation will occur 1
• Can be diluted in Normal Saline, Lactated Ringer's, or D5W after ensuring pH >5.5 1
• For small volumes like 3 mg (0.3 mL), consider diluting to 1-2 mL total volume with normal saline for more accurate administration

Critical Preparation Warnings

• Never add to running IV lines containing acidic medications (labetalol, ciprofloxacin, amrinone, milrinone) 1
• Inspect visually for particulate matter and discoloration before use 1
• Do not use if solution is discolored 1

Administration Methods

Method 1: Slow IV Push (Standard)

• Administer over 1-2 minutes as a slow IV push 1, 2
• This is the FDA-approved method for neonates 1
• Onset of action occurs within minutes intravenously 3
• Avoid rapid administration to prevent ototoxicity, especially at doses >6 mg/kg/day 4

Method 2: Continuous Infusion (Preferred for Critically Ill)

• Start at 0.1 mg/kg/hour (for a 3 kg infant = 0.3 mg/hour) 5
• Can increase to 0.4 mg/kg/hour if diuresis <1 mL/kg/hour 4
• Continuous infusion provides more controlled diuresis with fewer hemodynamic and electrolyte fluctuations compared to bolus dosing 5
• Requires dilution in compatible IV fluid (NS, LR, or D5W with pH >5.5) 1
• Infusion rate must not exceed 4 mg/min when using high-dose therapy 1

Evidence strongly supports continuous infusion over bolus in critically ill neonates: A randomized trial in 26 infants post-cardiac surgery showed continuous infusion (0.1 mg/kg/hour) produced comparable urine output with 50% less total drug dose, significantly less urinary output fluctuation (variance 1.9 vs 3.8, p=0.02), and 60% less fluid replacement needs (20.6 vs 51.8 mL, p=0.001) compared to 1 mg/kg boluses every 4 hours 5.

Pharmacokinetic Considerations in Neonates

Altered Drug Handling

• Half-life in neonates: 8-27 hours (vs 33-100 minutes in adults) 6, 7
• Clearance is 8-fold lower than adults 7
• Volume of distribution: 0.37-0.83 L/kg (4-fold greater than adults) 8, 7
• Very preterm neonates (<28 weeks) within first 2 weeks have mean clearance of 16.5 mL/kg/hour 8

Dosing Implications

• Serum creatinine is the strongest predictor of furosemide clearance: CL = 84.2 - 67.1 × SCr (mg/dL) 8
• Reduced clearance explains prolonged diuretic effect in neonates 7
• Repeat dosing should be cautious: Not sooner than 2 hours after previous dose, increasing by 1 mg/kg increments if needed 1

Monitoring Requirements

Immediate Monitoring (During/After Administration)

• Blood pressure continuously - risk of hypotension with rapid administration 2
• Heart rate and perfusion - assess capillary refill, pulse quality 9
• Urine output hourly - target >1 mL/kg/hour 9
• Oxygen saturation - especially in infants with pulmonary hypertension 9

Laboratory Monitoring

• Serum electrolytes (sodium, potassium, chloride) - risk of hypokalemia and metabolic alkalosis 3
• Serum calcium - risk of hypercalciuria leading to nephrocalcinosis 3
• Serum creatinine - monitor renal function 4
• Blood glucose - maintain euglycemia with D10% infusion at maintenance rate 9

Renal Ultrasonography

• Consider renal ultrasound monitoring in premature infants receiving chronic furosemide 1
• Nephrocalcinosis risk increases significantly with cumulative doses >10 mg/kg 10
• Risk is 48-fold higher with cumulative doses >10 mg/kg bodyweight 6

Critical Safety Considerations

Ototoxicity Prevention

• Avoid concurrent use with aminoglycosides 3, 11
• Infuse slowly (over 5-30 minutes for higher doses) to prevent hearing loss 4
• Risk increases with cumulative doses >100-120 g (not applicable to single 3 mg dose) 11

Nephrocalcinosis Risk

• Most significant in premature infants with chronic use 1, 10
• Incidence ranges 17-41% in very low birth weight infants receiving furosemide 10
• Approximately 60% resolve after discontinuation 10
• Limit cumulative exposure and consider thiazide/spironolactone combination as alternative 3

Drug Interactions

• Increased risk of patent ductus arteriosus persistence when given in first weeks of life 1
• Avoid with indomethacin - increased risk of acute renal failure 6
• Theophylline co-administration increases urine flow rate 6

Fluid Management

• Use only with intravascular fluid overload (good perfusion, high BP) 4
• Contraindicated in hypovolemia - can promote thrombosis 4
• Stop if anuria develops 4

Practical Algorithm for 3 mg Dose

1. Verify indication: Fluid overload with adequate perfusion, not hypovolemia
2. Check serum creatinine: Adjust expectations for clearance
3. Prepare: Draw 0.3 mL (3 mg) from 10 mg/mL vial
4. Dilute: Add to 1-2 mL NS for accuracy
5. Administer:
   • Stable infant: Slow IV push over 1-2 minutes
   • Critically ill/post-cardiac surgery: Consider continuous infusion at 0.1 mg/kg/hour
6. Monitor: BP, HR, urine output hourly, electrolytes within 24 hours
7. Reassess: If inadequate response after 2 hours, may increase dose by 1 mg/kg (not to exceed 2 mg/kg/day in premature infants)

The key distinction is that continuous infusion provides superior hemodynamic stability and more predictable diuresis in critically ill neonates, while slow IV push remains acceptable for stable infants with less severe fluid overload 5.